These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
242 related articles for article (PubMed ID: 35406673)
1. Newborn Screening: Review of its Impact for Cystinosis. Hohenfellner K; Elenberg E; Ariceta G; Nesterova G; Soliman NA; Topaloglu R Cells; 2022 Mar; 11(7):. PubMed ID: 35406673 [TBL] [Abstract][Full Text] [Related]
2. Outcome of infantile nephropathic cystinosis depends on early intervention, not genotype: A multicenter sibling cohort study. Veys K; Zadora W; Hohenfellner K; Bockenhauer D; Janssen MCH; Niaudet P; Servais A; Topaloglu R; Besouw M; Novo R; Haffner D; Kanzelmeyer N; Pape L; Wühl E; Harms E; Awan A; Sikora P; Ariceta G; van den Heuvel B; Levtchenko E J Inherit Metab Dis; 2023 Jan; 46(1):43-54. PubMed ID: 36117148 [TBL] [Abstract][Full Text] [Related]
3. Beneficial effects of starting oral cysteamine treatment in the first 2 months of life on glomerular and tubular kidney function in infantile nephropathic cystinosis. Hohenfellner K; Nießl C; Haffner D; Oh J; Okorn C; Palm K; Schlingmann KP; Wygoda S; Gahl WA Mol Genet Metab; 2022 Aug; 136(4):282-288. PubMed ID: 35843134 [TBL] [Abstract][Full Text] [Related]
4. Early oral cysteamine therapy for nephropathic cystinosis. Gahl WA Eur J Pediatr; 2003 Dec; 162 Suppl 1():S38-41. PubMed ID: 14610675 [TBL] [Abstract][Full Text] [Related]
5. Relationship between age at initiation of cysteamine treatment, adherence with therapy, and glomerular kidney function in infantile nephropathic cystinosis. Nießl C; Boulesteix AL; Oh J; Palm K; Schlingmann P; Wygoda S; Haffner D; Wühl E; Tönshoff B; Buescher A; Billing H; Hoppe B; Zirngibl M; Kettwig M; Moeller K; Acham-Roschitz B; Arbeiter K; Bald M; Benz M; Galiano M; John-Kroegel U; Klaus G; Marx-Berger D; Moser K; Mueller D; Patzer L; Pohl M; Seitz B; Treikauskas U; von Vigier RO; Gahl WA; Hohenfellner K Mol Genet Metab; 2022 Aug; 136(4):268-273. PubMed ID: 35835062 [TBL] [Abstract][Full Text] [Related]
6. Cysteamine in renal transplantation: A report of two patients with nephropathic cystinosis and the successful re-initiation of cysteamine therapy during the immediate post-transplant period. Berryhill A; Bhamre S; Chaudhuri A; Concepcion W; Grimm PC Pediatr Transplant; 2016 Feb; 20(1):141-5. PubMed ID: 26477696 [TBL] [Abstract][Full Text] [Related]
7. Nephropathic cystinosis in adults: natural history and effects of oral cysteamine therapy. Gahl WA; Balog JZ; Kleta R Ann Intern Med; 2007 Aug; 147(4):242-50. PubMed ID: 17709758 [TBL] [Abstract][Full Text] [Related]
8. Diagnostic challenge in a patient with nephropathic juvenile cystinosis: a case report. Higashi S; Matsunoshita N; Otani M; Tokuhiro E; Nozu K; Ito S BMC Nephrol; 2017 Sep; 18(1):300. PubMed ID: 28950840 [TBL] [Abstract][Full Text] [Related]
9. [Nephropathic cystinosis: report of 2 cases and review of the literature]. Knoepfelmacher M; Rocha R; Salgado LR; Semer M; Voss D; Wajchenberg BL; Liberman B Rev Assoc Med Bras (1992); 1994; 40(1):43-6. PubMed ID: 8061694 [TBL] [Abstract][Full Text] [Related]
10. Controversies and research agenda in nephropathic cystinosis: conclusions from a "Kidney Disease: Improving Global Outcomes" (KDIGO) Controversies Conference. Langman CB; Barshop BA; Deschênes G; Emma F; Goodyer P; Lipkin G; Midgley JP; Ottolenghi C; Servais A; Soliman NA; Thoene JG; Levtchenko EN; Kidney Int; 2016 Jun; 89(6):1192-203. PubMed ID: 27181776 [TBL] [Abstract][Full Text] [Related]
11. Pharmacological treatment of nephropathic cystinosis with cysteamine. Kleta R; Gahl WA Expert Opin Pharmacother; 2004 Nov; 5(11):2255-62. PubMed ID: 15500372 [TBL] [Abstract][Full Text] [Related]
13. Clinical and neurophysiological characterization of early neuromuscular involvement in children and adolescents with nephropathic cystinosis. Elkhateeb N; Selim R; Soliman NA; Atia FM; Abouelwoun II; Elmonem MA; Helmy R Pediatr Nephrol; 2022 Jul; 37(7):1555-1566. PubMed ID: 34791528 [TBL] [Abstract][Full Text] [Related]
14. Effects of long-term cysteamine treatment in patients with cystinosis. Ariceta G; Giordano V; Santos F Pediatr Nephrol; 2019 Apr; 34(4):571-578. PubMed ID: 29260317 [TBL] [Abstract][Full Text] [Related]
15. Negligible urinary cysteamine loss in cystinosis patients with Fanconi syndrome. Levtchenko EN; de Graaf-Hess A; Blom HJ; Monnens LA Clin Nephrol; 2002 May; 57(5):349-51. PubMed ID: 12036193 [TBL] [Abstract][Full Text] [Related]
16. Nephropathic cystinosis: an update on genetic conditioning. Topaloglu R Pediatr Nephrol; 2021 Jun; 36(6):1347-1352. PubMed ID: 32564281 [TBL] [Abstract][Full Text] [Related]
17. CTNS mRNA molecular analysis revealed a novel mutation in a child with infantile nephropathic cystinosis: a case report. Papizh S; Serzhanova V; Filatova A; Skoblov M; Tabakov V; van den Heuvel L; Levtchenko E; Prikhodina L BMC Nephrol; 2019 Oct; 20(1):400. PubMed ID: 31672123 [TBL] [Abstract][Full Text] [Related]